Faculty

Edward N. Libby MD

Edward N. Libby MD

Associate Professor
Department of Medicine
Division of Oncology
University of Washington
Associate Member
Clinical Research Division
Fred Hutchinson Cancer Research Center

Mailing Address

Seattle Cancer Care Alliance
825 Eastlake Ave E, G3-200
Seattle, WA 98109-1023

Admin Contact

Sonia Bill
206.288. 2035
sbill@seattlecca.org
Fax: 206.288.1130

Specialty / Expertise

  • Multiple myeloma
  • Plasma cell leukemia
  • Amyloidosis
  • Waldenstrom’s macroglobulinemia
  • Plasmacytoma
  • POEMS Syndrome
  • MGUS and smoldering multiple myeloma
  • Lymphoma

Research Interests

Multiple Myeloma
Amyloidosis
Waldenstrom's macroglobulinemia
Lymphoma

Current Research Projects

RV-FOL-GELARC-0683C (RELEVANCE-7636)
Funding Source: Celgene Corporation
A Phase 3 Open-Label Randomized Study to Compare the Efficacy and Safety of Rituximab plus Lenalidomide (CC-5013) versus Rituximab plus Chemotherapy Followed by Rituximab in Subjects with Previously Untreated Follicular Lymphoma.

Training

Dr. Libby received his B.S. from the University of Texas at El Paso and his M.D. from the University of Texas Health Science Center at Houston. He completed his Internal Medicine residency at the University of New Mexico(UNM) in Albuquerque. He was a Fellow in Hematology at UNM as well.

Selected Publications

Horwitz ME, Long G, Holman P, Libby E, Calandra GC, Schriber JR. Efficacy and Safety of Hematopoietic Stem Cell Remobilization with Plerixafor + G-CSF in Adult Patients with Germ Cell Tumor. Bone Marrow Transplant. 2012 Oct;47(10):1283-6. doi: 10.1038/bmt.2012.21. Epub 2012 Feb 20.

Libby E and Hromas R. editorial- Inside Blood: Closing the Door on MDR Inhibition in AML. Blood 2010 Nov 18;116(20):4037-8.

Libby E, Candelaria-Quintana D, Moualla H, Abdul-Jaleel M, Rabinowitz I. Durable complete remission of primary plasma cell leukemia with the bortezomib plus melphalan and prednisone (VMP) regimen (letter). Am J Hematol. 2010 Sep;85(9):733-4.

Libby E, Movva S, Quintana D, Abdul-Jaleel M, Das A. Diagnosis in Oncology: Cytomegalovirus Retinitis During Chemotherapy With Rituximab Plus Hyperfractionated Cyclophosphamide, Vincristine, Doxorubicin, and Dexamethasone. J Clin Oncol. 2010 Sep 20.

Wiggins CL, Harlan LC, Nelson HE, Stevens JL, Willman CL, Libby EN, Hromas RA. Age Disparity in the Dissemination of Imatinib for Treating Chronic Myeloid Leukemia. Am J Med. 2010 Aug;123(8):764.e1-9.

Garcia D, Libby E, Crowther M. The Novel Anticoagulants. Blood 2010 Jan 7;115(1):15-20.

Sayar H, Bunning JT, Bocklage TJ, Lee SJ, Libby E, Rabinowitz I. Tumor MET expression may not predict the risk of venous thromboembolism in cancer patients. Oncol Res. 2010;19(2):93-7.

Oertel LB, Libby EN. Is patient self-testing a good thing? J Thromb Thrombolysis. 2010 Feb;29(2):214-8.

Wray J, Williamson E, Sheema S, Lee s, Libby E, Willman C, Nickoloff J, Hromas R. Metnase Mediates Chromosome Decatenation in Acute Leukemia Cells. Blood.2009 Aug 27;114(9):1852-8.

Garcia D, Highfill J, Finnerty K, Varoz E, McConkey S, Hutchinson K, Libby E. A prospective controlled trial of a pharmacy-driven alert system to increase thromboprophylaxis rates in medical inpatients. Blood Coagul Fibrinolysis. 2009 Oct;20(7):541-5.

J. Bibb, E. Fischer, S. Lee, E. Libby & I. Rabinowitz : The Utility of Bayes' theorem in positron emission tomography positive suspected cases of relapsed non-Hodgkin's lymphoma.The Internet Journal of Oncology. 2009 Volume 6 Number 2.

Libby E. Pregnancy and Thromboembolic Disease. Thromb Res.2008;123 Suppl 1:S55-7.

Nguyen D,Lee SJ, Libby E, Verschraegen C. Rate of Thromboembolic Events in Mesothelioma. Ann Thorac Surg. 2008 Mar;85(3):1032-8.

Libby E, Booker J,Gulley M, Garcia D, Moll S. False Negative Factor V Leiden Genetic Testing in a Patient with Recurrent Deep Venous Thrombosis. Am J. Hem 81:284-289,2006.

Garcia D, Ageno W, Libby E. Pulmonary Embolism A Review of Current Trends in Evaluation and Treatment. Br J Haematol 2005 Nov;131(3):301-12.

Garcia D, Libby E, Rich J. Perioperative Anticoagulation for Patients with Mechanical Heart Valves: A model Comparing Unfractionated and Low-Molecular-Weight Heparin. Journal of Clinical Outcomes Management 2005;12(1):25-31.

Garcia, D. Ageno, W. Libby, E. Bibb, J. Douketis, J. Crowther, M. "Perioperative anticoagulation for patients with mechanical heart valves: a survey of current practice." J Thromb Thrombolysis, January 1, 2005; 18(3): 199-203.

Weinsheimer RL, Libby E, Howdieshell TR. Life-Threatening Abdominal Wall Hematoma in chronic Renal Failure Patient After a Single Dose of Enoxaparin. The American Surgeon 2005;71(2):132-134.

Ageno W, Garcia D ,Libby E, Crowther M. Managing oral anticoagulant therapy in patients with mechanical heart valves undergoing elective surgery: results of a survey conducted among Italian physicians. Blood, Coagulation and Fibrinolysis 2004,15:623-628.

Libby E, White G. Intracranial Pseudotumor in Haemophilia. Haemophilia 2004;10:186-188. Libby E. Garcia D. A Survey of Vitamin K Use by Anticoagulation Clinics. Archives of Internal Medicine, 2002; 162(16): 1893-1896.

Last updated: February 2014

Top